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Abstract 
           
We address the problem of generating novel molecules with desired interaction properties as a multi-
objective optimization problem. Interaction binding models are learned from binding data using graph 
convolution networks (GCNs). Since the experimentally obtained property scores are recognised as 
having potentially gross errors, we adopted a robust loss for the model. Combinations of these terms, 
including drug likeness and synthetic accessibility, are then optimized using reinforcement learning 
based on a graph convolution policy approach. Some of the molecules generated, while legitimate 
chemically, can have excellent drug-likeness scores but appear unusual. We provide an example based 
on the binding potency of small molecules to dopamine transporters. We extend our method 
successfully to use a multi-objective reward function, in this case for generating novel molecules that 
bind with dopamine transporters but not with those for norepinephrine. Our method should be 
generally applicable to the generation in silico of molecules with desirable properties. 
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1  Introduction 
The in silico (and experimental) generation of molecules or materials with desirable properties is an 
area of immense current interest (e.g.  [1-28]). However, difficulties in producing novel molecules by 
current generative methods arise because of the discrete nature of chemical space, as well as the large 
number of molecules [29]. For example, the number of drug-like molecules has been estimated to be 
between 1023 and 1060 [30-34]. Moreover, a slight change in molecular structure can lead to a drastic 
change in a molecular property such as binding potency (so-called activity cliffs [35-37]).  
Earlier approaches to understanding the relationship between molecular structure and properties 
used methods such as random forests [38, 39], shallow neural networks [40, 41], Support Vector 
Machines [42], and Genetic Programming [43]. However, with the recent developments in Deep 
Learning [44, 45], deep neural networks have come to the fore for property prediction tasks [3, 46-
48]. Notably, Coley et al. [49]] used Graph convolutional networks effectively as a feature encoder for 
input to the neural network. 
In the past few years, there have been many approaches to applying Deep Learning for molecule 
generation. Most papers use the Simplified Molecular-Input Line-Entry System (SMILES) strings as 
inputs [50], and many use a Variational AutoEncoder architecture (e.g. [3, 17, 51]), with Bayesian 
Optimization in the latent space to generate novel molecules. However, the use of a sequence-based 
representational model has a specific difficulty, as any method using them has to learn the inherent 
rules, in this case of SMILES strings. More recent approaches, such as Grammar Variational 
AutoEncoders [52, 53] have been developed in attempts to overcome this problem but still the 
molecules generated are not always valid. Some other approaches try to use Reinforcement Learning 
for generating optimized molecule [54]. However, they too make use of SMILES strings which as 
indicated poses a significant problem. In particular, the SMILES grammar is entirely context-sensitive: 
the addition of an extra atom or bracket can change the structure of the encoded molecule 
dramatically, and not just ‘locally’ [55].  
Earlier approaches have tended to choose a specific encoding for the molecules to be used as an input 
to the model, such as one hot encoding [56, 57], Extended Connectivity Fingerprints [58, 59] and 
Generative Examination Networks [60] use SMILES strings directly. We note that these encodings do 
not necessarily capture the features that need to be obtained for prediction of a specific property (and 
all encodings extract quite different and orthogonal features [61]).  
In contrast, the most recent state-of-the-art methods, including hypergraph grammars [62], Junction 
Tree Variational Auto Encoders [63] and Graph Convolutional Policy Networks [34], use a graphical 
representation of molecules rather than SMILES strings and have achieved 100% validity in molecular 
generation. Graph-based methods have considerable utlility (e.g. [64-70] and can be seen as a more 
natural representation of molecules as substructures map directly to subgraphs, but subsequences 
are usually meaningless. However, these have only been used to compare the models on deterministic 
properties such as the Quantitative Estimate of Drug-likeness (QED) [71], logP, etc. that can be 
calculated directly from molecular structures (e.g. Using RDKit, http://www.rdkit.org/).  For many 
other applications, molecules having a higher score for a specific measured property are more useful. 
We here try to tackle this problem.  
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Figure 1. Block diagram of our basic system. A molecule is generated by the Reinforcement Learning 
(RL) pathway using a Graph Convolutional Policy Networks. This molecule is then used as an input for 
the property prediction module which outputs the property score as predicted by the module. This 
score is then used as the reward feedback for the RL pathway and the cycle restarts 
 
 
2. Methods 
Our system consists of two parts: Property Prediction and Molecular  Generation. For both the parts, 
we represent the molecules as graphs [72] since they are a more natural representation than are 
SMILES strings, and substructures are simply subgraphs.  We train a model to predict the property 
scores of the molecules, specifically the binding constant of various molecules at the dopamine and 
norepinephrine transporters (using a dataset from BindingDB). The first part, used for (training) the  
property prediction part, is a Graph Convolutional Network as a feature encoder together with a Feed 
Forward Network. We also use an Adaptive Robust Loss Function (as suggested by [73]) since the 
experimental data are bound to be error prone. For the Molecular Generation task, we use the method 
proposed by You and colleagues [34]. In particular, we (and they) use Reinforcement Learning for this 
task since it allows us to incorporate both the molecular constraints and the desired properties using 
reward functions. This part uses graph convolution policy networks (GCPNs), a model consisting of a 
GCN that predicts the next action (policy) given the molecule state.  It is further guided by expert 
pretraining and adversarial loss for generating valid molecules. Our code 
(https://github.com/dbkgroup/prop_gen) is essentially an integration of the property prediction code 
of Yang and colleagues [74, 75] (https://github.com/swansonk14/chemprop) and the reinforcement 
learning code provided by You and colleagues [34]. 
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2.1 Molecular Property Prediction  
As noted, the supervised property prediction model consists of a graph-convolution network for 
feature extraction followed by a fully interconnected feedforward network for property prediction.  
2.1.1 Feature Extraction  
We represent the molecules as directed graphs, with each atom (𝑖) having a feature vector 𝐹𝑖 (ℝ
133 ) 
and each bond (between atom 𝑖 & 𝑗) having feature vector 𝐹𝑖𝑗 (ℝ
14 ).  For each incoming bond a 
feature vector is obtained by concatenating the feature vector of the atom to which the bond is 
incoming and the feature vector of the bond. Thus the input tensor is of the size 𝑁bonds x ℝ147 . The 
Graph Convolution approach allows the message (feature vector) for a bond to be passed around the 
entire graph using the approach described below. 
The initial atom-bond feature vector that we use incorporates important molecular information that 
the GCN encoder can then incorporate in later layers. The initial representations for the atom and 
bond features are taken from https://github.com/swansonk14/chemprop and summarized in Table 1, 
below. Each descriptor is a one-hot vector covering the index-range represented by it (except the 
Atomic Mass). For Atomic Number, Degree, Formal Charge, Chiral Tag, Number of Hydrogens and 
Hybridization, the feature vector contains one additional dimension to allow uncommon values 
(values not in the specified range).  
 
INDICES ATOM DESCRIPTION 
0 – 100  Atomic Number (1 to 100) 
101-107 Degree (1 to 5) 
108-113 Formal Charge (-2 to + 2) 
114-118 Chiral Tag (0 to 4) 
119-124 Number of Hydrogens (0 to 4) 
125-130 Hybridization (SP, SP2, SP3, SP3D, SP3D2) 
131 Aromatic Atom 
132 Atomic Mass * 0.01 
INDICES BOND DESCRIPTION 
133 Bond Present  
134-136 
137 
Bond Type (Single, Double, Triple) 
Aromatic Bond  
138 Conjugated Bond 
139 Bond present in Ring 
140-146 Bond Stereo Code (RdKit) 
Table 1. Atom and bond features used in the present work 
The initial atom-bond feature vector is then passed through a linear layer followed by ReLU Activation 
[76, 77] to get the Depth-0 message vector for each bond. For each bond, the message vectors for the 
neighbouring bonds are summed up (Convolution step) and passed through a linear layer followed by 
ReLU and a Dropout layer to get the Depth-1 message vectors. This process is continued up to a 
specified Depth-(N-1) message vectors. To get the Depth-N message vectors, the Depth-(N-1) vectors 
of all the incoming bonds  for an atom are summed and then passed through a dense layer followed 
by ReLU and Dropout. The final graph embedding for the molecule is obtained by averaging  the depth-
N message vectors over all the atoms. The exact details for this model can be found in section 3.1.1. 
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Figure 2. The property prediction pipeline for our method. The steps in green represent the 
feature extraction using Graph Convolution and the steps in orange represent regression of 
property scores. (a) The molecule is represented is a feature vector with features described 
as in section 2.1. (b) The feature vector is passed through a linear layer to get Depth-0 
message. (c) Through repeated graph convolution (message passing) followed by  Linear 
Layer, we get Depth N-1 message.  (d) Each atom’s final message is calculated by summing 
up the messages (also Graph Convolution) of the neighbouring atoms. (e) The resultant 
message is  passed through a Linear Layer and the mean of all the atoms is taken to get the 
final embedding. (f) The property score is regressed from the graph embedding by a Feed 
Forward Neural Network. (g) The loss between predicted property and ground truth 
property is then backpropagated to change the weights. 
 
2.1.2 Regression 
To perform property prediction the embedding extracted by the GCN is fed into a fully connected 
network. Each intermediate layer consists of a Linear Layer followed by  ReLU activation and Dropout 
that map the hidden vector to another vector of the same size. Finally the penultimate nodes are 
passed through a Linear Layer to output the predicted property score. The Ki values present in the 
dataset were obtained experimentally so might contain experimental errors. If we were to train our 
model with a simple loss function such as root mean square (RMS) error loss, it would not be able to 
generalize well because of the presence of outliers in the training set. Overcoming this problem 
requires training the data with the help of a robust loss function that takes care of the outliers present 
in the training data. There are several types of robust loss functions such as Pseudo-Huber loss [78], 
Cauchy loss, etc., but each of them has an additional hyperparameter value (for example δ in Huber 
Loss) which is treated as a constant while training. This means that we have to manually tune the 
hyperparameter each time we train to get the optimum value which may result in extensive training 
time. To overcome this problem , as proposed by [73], we have used a general robust loss function 
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that has the hyperparameters as shape parameter (α)  which controls the robustness of the loss, and 
the scale parameter (c) which controls the size of the loss’s quadratic bowl near x=0. This loss is 
dubbed as a “general” loss since it takes the form of other loss functions for particular values of α. (e.g 
L2 loss for α=2, Charbonnier loss for α=1, Cauchy loss for α=0). The authors also propose that “by 
viewing the loss function as the negative log likelihood of a probability distribution, and by treating 
robustness of the distribution as a latent variable” we can use gradient-based methods to maximize 
the likelihood without manual parameter tuning. In other words, we can now train the 
hyperparameters α and c rather which overcomes the earlier problem of manually tuning the 
hyperparameters. The loss function and the corresponding probability distribution are described in 
Eq. 1 and Eq. 2 respectively. 
 
 𝑓(𝑥, α, 𝑐) =  
|α − 2|
α
((
(𝑥/𝑐)2
|α − 2|
+ 1)
α/2
− 1) Eq. 1 
 
𝑝(𝑥|α, 𝑐) =
1
𝑐𝑍(α)
exp(−𝑓(𝑥, α, c)) 
𝑍(α) = ∫ exp (−𝑓(𝑥, α, 1)
∞
−∞
 
Eq. 2 
 
2.2 Reinforcement Learning for Molecular Generation 
We follow the method described by the GCPN paper [34] for the molecular generation task, with the 
difference being that the final property reward is the value calculated by the previously trained model 
for the newly generated molecules. GCPN is a state-of-the-art molecule generator that utilizes 
Proximal Policy Optimization (PPO) as a Reinforcement Learning paradigm for generating molecules. 
A comparison of GCPN with other generative approaches can be found in Table 2 and Table 3 which 
compare the ability of generators to produce molecules having higher property scores and targeted 
property scores, respectively. Note that even though we have chosen GCPN for the molecule 
generation pipeline, our strategy can be implemented using any graph-based Reinforcement Learning 
generator since we just need to use the predicted property score as the reward function.  
Method 
Penalized logP QED 
1st 2nd 3rd Validity 1st 2nd  3rd Validity 
ZINC 4.52  4.30 4.23 100% 0.948 0.948 0.948 100% 
ORGAN 3.63 3.49 3.44 0.4% 0.896 0.824 0.820 2.2% 
JT-VAE 5.30 4.93 4.49 100% 0.925 0.911 0.910 100% 
GCPN 7.98 7.85 7.80 100% 0.948 0.947 0.946 100% 
Table 2: Comparison of the top 3 property scores of generated molecules found by each model. 
Validity is defined as the fraction of generated molecules that are chemically valid. ORGAN and JT-
VAE are described in [79] and [63], respectively. 
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Method 
−2.5 ≤ logP ≤ −2 5 ≤ logP ≤ 5.5 150 ≤ MW ≤ 200 500 ≤ MW ≤ 550 
Success Diversity Success Diversity Success Diversity Success Diversity 
ZINC 0.3% 0.919 1.3% 0.909 1.7% 0.938 0 - 
ORGAN 0 - 0.2% 0.909 15.1% 0.759 0.1% 0.907 
JT-VAE 11.3% 0.846 7.6% 0.907 0.7% 0.824 16.0% 0.898 
GCPN 85.5% 0.392 54.7% 0.855 76.1% 0.921 74.1% 0.920 
Table 3: Comparison of the effectiveness of property targeting task. MW here stands for the 
Molecular Weight. Success is defined as the percentage of generated molecules in the target range 
and Diversity is defined as the average pairwise Tanimoto distance between the Morgan fingerprints 
of the molecules. Citations to ORGAN and JT-VAE are given in the legend to Table 2. 
 
2.2.1 Molecular Representation 
As in the previous part, we represent the molecules as graphs, more specifically as (𝐴, 𝐸, 𝐹) where 𝐴 
∈ {0, 1}𝑛×𝑛  is the adjacency matrix, 𝐹 ∈ ℝ𝑛×𝑑 is the node (atom) feature matrix and 𝐸 ∈
 {0, 1}3×𝑛×𝑛   is the edge-conditioned adjacency tensor (since the number of bond-types is 3, namely 
single, double and triple bond), with  𝑛 being the number of atoms and 𝑑 being the length of feature 
vector for each atom. More specifically, 𝐸𝑖,𝑗,𝑘 =  1 if there exists a bond of type 𝑖 between atoms 𝑗 
and 𝑘 , and 𝐴𝑗,𝑘 = 1 if there exists any bond between atoms 𝑗 and 𝑘. 
 
2.2.2 Reinforcement Learning setup 
Our model environment builds a molecule step by step with the addition of a new bond in each step.   
We treat graph generation as a Markov Decision Process such that the next action is predicted based 
only on the current state of the molecule, not on the path that the generative process has taken. This 
reduces the need for sequential models such as RNNs and the disadvantages of vanishing gradients 
associated with them, as well as reducing the memory load on the model. More specifically, the 
decision process follows the equation: 𝑝 (𝑠𝑡+1 |𝑠𝑡, . . . 𝑠0 ) =  𝑝(𝑠𝑡+1|𝑠𝑡 ), where p is the probability of 
next state (𝑠𝑡+1) given the previous state (𝑠𝑡). 
We can initialize the generative process with either a single C atom (as in Experiments 1 and 2) or with 
another molecule (as in Experiments 3, 4  and 5). At any point in the generation process, the state of 
the environment is the graph of the current molecule that has been built up so far. The action space 
is a vector of length 4 which contains the information – First Atom, Second Atom, Bond type and Stop.  
The stop signal is either 0 or 1 indicating whether the generation is complete, based on valence rules. 
If the action defies the rules of chemistry in the resultant molecule, the action is not considered and 
the state remains as it is.  
We make use of both intermediate and final rewards to guide the decision-making process. The 
intermediate rewards include stepwise validity checks such that a small constant value is added to the 
reward if the molecule passes the valency checks. The final reward includes the pKi value of the final 
molecule as predicted by the trained model and the validity rewards (+1 for not having any steric strain 
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and +1 for absence of functional groups that violate ZINC functional group filters). Two other metrics 
are the quantitative estimation of drug-likeness (QED) [71] and the synthetic accessibility (SA) [80] 
score.  Since our final goal is to generate drug-like molecules that can be synthetically generated, we 
also add the QED and 2*SA score of the final molecule to the reward. 
Apart from this, we also use adversarial rewards so that the generated molecules resemble 
(prediction) the given set of molecules (real). We define the adversarial rewards  𝑉(𝜋𝛳, 𝐷Ф)  in Eq 3.                     
 min
𝜃
 max
𝜙
 𝑉(𝜋𝜃, 𝐷𝜙) = 𝐸𝑥∼𝑝data[log𝐷𝜙(𝑥)] + 𝐸𝑥∼𝜋𝜃[log𝐷𝜙(1 − 𝑥)] Eq. 3 
where 𝜋𝜃 is the policy network, 𝐷𝜑 is the discriminator network, 𝑥 represents the input graph and 
𝑝data is the underlying data distribution which is defined either over final graphs (for final rewards) or 
intermediate graphs (for intermediate rewards) (just as proposed by You and colleagues  [34]). 
Alternate training of generator (policy network) and discriminator by gradient descent methods will 
not work in our case since 𝑥 is a non-differentiable graph object. Therefore we add  – 𝑉(𝜋𝛳, 𝐷Ф)  to 
our rewards and use policy gradient methods [81] to optimize the total rewards. The discriminator 
network comprises a Graph Convolutional Network for generating the node embedding and a Feed 
Forward Network to output whether the molecule is real or fake. The GCN mechanism is same as that 
of the policy network which is described in the next section. 
 
2.2.3 Graph Convolutional Policy Network  
We use Graph Convolutional Networks (GCNs) as the policy function for the bond prediction task. This 
variant of graph convolution performs message passing over each edge type for a fixed depth 𝐿.  “The 
node embedding for the next depth (𝑙 +  1) is calculated as described in Eq. 4 
 
 
where 𝐸𝑖  is the 𝑖
𝑡ℎ slice of the tensor 𝐸 ,  ?̃?𝑖 =  𝐸𝑖 + 𝐼 , ?̃?𝑖 = ∑ ?̃?𝑖𝑗𝑘𝑘 ,   𝑊𝑖
(𝑙) is a trainable weight matrix 
for the 𝑖𝑡ℎ edge type, and 𝐻(𝑙) is the node embedding learned in the 𝑙𝑡ℎ layer with 𝐻(𝑙)  ∈  ℝ(𝑛+𝑐)×𝑑 
[34]. 𝑛 is the number of atoms in the current molecule and 𝑐 is the number of possible atom types 
(C,N,O etc.) that can be added to the molecule (one atom is added in each step) with 𝑑 representing 
the dimension of the embedding. We use mean over the edge features as the Aggregate (AGG) 
function to obtain the node embedding for a layer. This process is repeated 𝐿 times until we get the 
final node embedding. 
This node embedding 𝑋 is then used as the input to four Multilayer Perceptrons (MLP, denoted by 𝑚), 
that map a matrix 𝑍 ∈ ℝ𝑝×𝑑  to ℝ𝑝 representing the probability of selecting a particular entity from 
the given 𝑝 entities. The specific entity is then sampled from the probability distribution thus obtained. 
Note that since the action space is a vector of length 4, we use 4 perceptrons to sample each 
   
𝐻(𝑙+1) = AGG (ReLU ({?̃?𝑖
−1
2 ?̃?𝑖?̃?𝑖
−1
2 𝐻(𝑙)𝑊𝑖
(𝑙)}, ∀𝑖 ∈ (1, … , 𝑏))) Eq. 4 
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component of the vector. The first atom has to be from the current molecule state while the second 
atom can be from the current molecule (forming a cycle) or a new atom outside the molecule (adding 
a new atom). For selecting the first atom, the original embedding 𝑋 is passed to the MLP 𝑚𝑓  and 
outputs a vector of length equal to 𝑛. While selecting the second atom, the embedding of first atom 
𝑋𝑎first  is concatenated to the original embedding 𝑋 and passed to the MLP 𝑚𝑠 giving a vector of length 
equal to 𝑛 + 𝑐. While selecting the edge type, the concatenated embedding of the first (𝑋𝑎first) and 
second (𝑋𝑎second) atom is used as an input to MLP 𝑚𝑒 and outputs a vector of length equal to 3 
(number of bond types). Finally, the mean embedding of the atoms is passed to MLP 𝑚𝑡 to output a 
vector of length 2 indicating whether to stop the generation. This process is described in equations 5-
9. 
Figure 3. The reinforcement learning pathway for systemic generation of molecules (Redrawn from 
You et al. [34]) . (a) The state is defined as the current graph 𝐺𝑡 and the possible atom types 𝐶. (b) The 
GCPN conducts message passing to encode the state as node embeddings and estimates the policy 
function. (c) The action to be performed (𝑎𝑡) is sampled from the policy function. The environment 
performs a chemical valency check on the intermediate state and returns (d) the next state 𝐺𝑡 and  (e) 
the associated reward (𝑟𝑡)  
                
2.2.4 Policy Gradient Training 
For our experiments, we use Proximal Policy Optimization (PPO) [81], the state-of-the-art policy 
gradient method, for optimizing the total reward. The objective function for PPO is described in Eq 10. 
 𝑎𝑡 = CONCAT(𝑎first, 𝑎second, 𝑎edge, 𝑎step)   Eq. 5 
 𝑓first(𝑠𝑡) = SOFTMAX (𝑚𝑓(𝑋))          𝑎first ∼ 𝑓first(𝑠𝑡) ∈ \{0,1\}
𝑛   Eq. 6 
 𝑓second(𝑠𝑡) = SOFTMAX (𝑚𝑠 (𝑋𝑎𝑓𝑖𝑟𝑠𝑡 , 𝑋))     𝑎second ∼ 𝑓second(𝑠𝑡) ∈ \{0,1\}
𝑛+𝑐   Eq. 7 
 𝑓edge(𝑠𝑡) = SOFTMAX (𝑚𝑒(𝑋𝑎first , 𝑋𝑎second))       𝑎edge ∼ 𝑓edge(𝑠𝑡) ∈ \{0,1\}
𝑏   Eq. 8 
 𝑓stop(𝑠𝑡) = SOFTMAX (𝑚𝑡(AGG(𝑋)))         𝑎stop ∼ 𝑓stop(𝑠𝑡) ∈ \{0,1\}   Eq. 9 
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Here 𝑠𝑡, 𝑎𝑡, 𝑅𝑡 are the state, action and reward respectively at timestep 𝑡, 𝑉(𝑠𝑡) is the value associated 
with state 𝑠𝑡, 𝜋𝜃 is the policy function and 𝛾 is the discount factor.  Also note that ?̂?𝑡, which is an 
estimator of the advantage function at timestep 𝑡, has been estimated using Generalized Advantage 
Estimation [82] with the GAE parameter 𝜆, since it  reduces the variance of the estimate.  
For estimating the value of 𝑉 we use an MLP with the embedding 𝑋 as the input. Apart from this, we 
also use expert pretraining [83] which has shown to stabilise the training process. For our experiment, 
any ground truth molecule can be used as an expert for imitation. We randomly select a subgraph 𝐺’ 
from the ground truth molecule 𝐺 ̂as the state ?̂?𝑡. The action ?̂?𝑡  is also chosen randomly such that it 
adds an atom or bond in the graph 𝐺\𝐺’ . This pair (?̂?𝑡, ?̂?𝑡) is used for calculating the expert loss.  
 min𝐿EXPERT(𝜃) = −log(𝜋𝜃(?̂?𝑡|?̂?𝑡))     Eq. 11 
Note that we use the same dataset of ground truth molecules for calculating the expert loss and the 
adversarial rewards. For the rest of the paper, we will call this dataset the “expert dataset” and the 
random molecule selected from the dataset the “expert molecule”.                                                 
 
3. System evaluation 
In this section we evaluate the system described above on the task of generating small molecules that 
interact with the dopamine transporter but not (so far as possible) with the norepinephrine 
transporter. 
3.1 Property Prediction 
In this section we evaluate the performance of the supervised property prediction component. 
Dopamine Transporter binding data was obtained from www.bindingdb.org (https://bit.ly/2YACT5u).  
The training data consist of some molecules which are labelled with their Ki values and some which 
are labelled with IC50 values. For this paper, we have used IC50 values and Ki values interchangeably in 
order to increase the size of the training dataset. Molecules having large Ki values in the dataset were 
not labelled accurately (with labels such as ~1000) but the use of a robust loss function allowed us to 
incorporate these values directly. As stated above we use log transformed values (pKi). (We also 
attempted to learn the Ki values of the molecules, but the distribution was found to be 
heteroscedastic; hence we focus on predicting the pKi values.) Data are shown in Fig 4A for the 
dopamine transporter and 4B for the norepinephrine transporter pKi values. 
 
 
max𝐿CLIP(𝜃) = 𝔼𝑡[min(𝑟𝑡(𝜃)?̂?𝑡,clip(𝑟𝑡(𝜃), 1 − 𝜖, 1 + 𝜖)?̂?𝑡)] 
𝑟𝑡(𝜃) =
𝜋𝜃(𝑎𝑡|𝑠𝑡)
𝜋𝜃old(𝑎𝑡|𝑠𝑡)
 
?̂?𝑡 = 𝛿𝑡 + (𝛾𝜆)𝛿(𝑡+1) + ⋯ + (𝛾𝜆)
𝑇−𝑡+1𝛿𝑇−1 
where      𝛿𝑡 = 𝑅𝑡 + 𝛾𝑉(𝑠𝑡+1) − 𝑉(𝑠𝑡) 
       Eq. 10 
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Figure 1 : Predicted and experimental values for the test sets of the dopamine (A) and norepinephrine 
(B) transporters. Lines are lines of best fit (A: y =0.44 + 0.79x, r2 = 0.79; B: y = 0.49 + 0.74x, r2 =0.68). 
 
3.1.1 Hyperparameter Optimization 
As the property prediction is a general algorithm with a large number of hyperparameters, we 
attempted to improve generalisation on the transporter problem using Bayesian optimization on the 
RMSE error between the predicted pKi values and the actual pKi values of the validation set. For this 
task we consider the hyperparameters to be the depth of the GCN encoder, the dimensions of the 
13 
 
message vectors, the number of layers in the Feed Forward Network, and the Dropout constant. We 
use 10-fold cross validation on the train and validation dataset with the test set held out. The model 
score is defined as the mean RMS error of the 10 folds and we use Bayesian optimization to minimize 
the model score.  
For the case of the dopamine transporter, the optimum hyperparameters that were obtained are 3 
(depth of GCN), 1300 (dimensions of message vector), 2 (FFN layers) and 0.1 (Dropout).The RMS error 
on the test dataset  for the dopamine transporter after Hyperparameter Optimization was found to 
be 0.57 as compared to an error of 0.65 without it. We attribute this quite significant remaining error 
to the errors present in the dataset. Similarly for the norepinephrine transporter , the test RMS error 
was found to be 0.66 after hyperparameter optimization and the optimum hyperparameters obtained 
are 5 (depth of GCN), 900 (dimensions of message vector), 3 (FFN layers), 0.15 (Dropout). 
3.1.2 Implementation details 
For the prediction of pKi value of both Dopamine and Norepinephrine transporters, we split the overall 
dataset into train (80%) , validation (10%) and test (10%) datasets randomly. The training is done with 
a batch size of 50 molecules and  for 100 epochs. All the network weights were initialized using Xavier 
initialization [84]. The first two epochs are warmup epochs [85] where the learning rate increases from 
1e-4 to 1e-3 linearly and after that it decreases exponentially to 1e-4 by the last epoch. The model is 
saved after an epoch if the RMS error on the validation dataset is less than the previous best and the 
error for the test dataset is calculated using the saved model which has the least error on the 
validation dataset. The code was written in PyTorch library and the training was done using an NVIDIA 
RTX 2080Ti GPU on a Windows 10 system with 256GB RAM and Intel 18-Core Xeon W-2195 processor. 
3.2 Single-Objective Molecular Generation 
To begin the RL evaluation we consider molecular generation with a single objective (dopamine 
transporter interaction). For all the experiments we use the following implementation details. The 
learning rate for training all the networks is taken to be 1e-3 and linearly decreasing to 0 by 3e7 
timesteps. The depth of GCN network for both the GCPN and the Discriminator network is taken to be 
3 and the node embedding size was taken to be 128. The code was written using the TensorFlow 
library and training was done using an NVIDIA RTX 2080Ti GPU as per the previous paragraph. 
For the task of analysing the results we provide the ‘top 10’ molecules generated as in  Fig 5. However, 
we aim to generate molecules that are in some sense similar to the original training dataset by 
systematically modifying the RL pathway in the following experiments. For each experiment, we find 
the closest molecule in the BindingDB dataset to the top 10 generated molecules. The relative 
closeness is measured by calculating its Tanimoto Similarity between the RDKit fingerprints and 
visualize the distribution of the TS values.  
First, we initialize the molecule with a single Carbon atom in the beginning of the generative process. 
The expert dataset in this case is chosen to be the ZINC dataset [86], which is a free dataset containing 
(at that time) some 230M commercially available compounds. However, for our experiments, we use 
250K randomly selected molecules from ZINC as our expert dataset to make the experiments 
computationally tractable. The top generated molecules and their predicted properties are given in 
Supplementary Table 1 (including data on QED and SA) with a subset of the data illustrated in Fig 5. 
Note that in all cases the values of QED and SA both exceeded 0.8.  
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Figure 5. In silico generation by DeepGraphMolGen of novel molecules with predicted binding capacity 
to the dopamine transporter. Molecules were generated as described in the text. A. Top 10 molecules 
as predicted by DeepGraphMolGen versus the closest molecule in the BindingdB dataset and the 
Tanimoto similarity thereto (encoded using the RDKit patterned fingerprint). B. Distribution of 
Tanimoto similarities to a molecule in BindingdB dataset of the top 500 molecules.  
 
Although the above experiment was able to generate  optimized molecules, there is no certainty that 
the predictions are correct due to the errors in the model as well as the errors that were propagated  
by the experimental errors in the data. We thus attempt to generate molecules that are similar to the 
more potent molecules. In the next experiment, we choose the expert dataset to be the original 
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dataset on which we trained the molecules (we will call this the Dopamine Dataset), while omitting 
molecules having Ki greater than 1000. We again choose the initial molecule to be a single carbon 
atom. The equivalent data are given in Supplementary Table 2, with similar plots to those of Fig 5 given 
in Fig 6.  
 
 
Figure 6. In silico generation by DeepGraphMolGen of novel molecules with predicted binding capacity 
to the dopamine transporter. Molecules were generated as described in the text. A. Top 10 molecules 
as predicted by DeepGraphMolGen versus the closest molecule in the BindingdB dataset and the 
Tanimoto similarity thereto (encoded using the RDKit patterned fingerprint). B. Distribution of 
Tanimoto similarities to a molecule in BindingdB dataset of the top 500 molecules.  
 
16 
 
Another way to ensure that the generated molecules will have a high affinity towards dopamine 
transporter is to explicitly ensure that the molecules have higher TS with already known molecules 
that have high pKi values. We attempt to achieve this by initializing the generative process with a 
random molecule from the Dopamine Dataset having Ki < 1000. We conduct two experiments using 
this process, one where we restrict the number of atoms (other than hydrogen) to be lower than 25 
(Supplementary Table 3 and Fig 7), and another ( Supplementary Table 4 and Fig 8) where we restrict 
the number of atoms to be less than 15. For both these experiments, we use the ZINC dataset as the 
expert dataset. The results are summarized in the tables below. Note that in some cases we obtain a 
TS of 1; this is encouraging as in this case the algorithm found no need to add anything to the original 
molecule and could recapitulate it. 
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Figure 7. In silico generation by DeepGraphMolGen of novel molecules with predicted binding 
capacity to the dopamine transporter using a generative method in which the number of heavy 
atoms is constrained to be lower than 25. Molecules were generated as described in the text. A. Top 
10 molecules as predicted by DeepGraphMolGen versus the closest molecule in the BindingdB 
dataset and the TS thereto (encoded using the RDKit patterned fingerprint). B. Distribution of 
Tanimoto similarities (RDKit patterned encoding) to a molecule in BindingdB dataset of the top 500 
molecules.  
 
 
 
Figure 8. In silico generation by DeepGraphMolGen of novel molecules with predicted binding 
capacity to the dopamine transporter using a generative method in which the number of heavy 
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atoms is constrained to be lower than 15. Molecules were generated as described in the text. A. Top 
10 molecules as predicted by DeepGraphMolGen versus the closest molecule in the BindingdB 
dataset and the TS thereto (encoded using the RDKit patterned fingerprint). B. Distribution of 
Tanimoto similarities (RDKit patterned encoding) to the closest molecule in BindingdB dataset of the 
top 500 molecules.  
 
3.3 Multi-Objective Molecular Generation 
Even though generating molecules having higher affinity towards a particular ligand in itself is quite 
sought after, in many cases we might wish to seek molecules that bind to one receptor but explicitly 
do not bind to another one (kinase inhibitors might be one such example). We attempt to achieve this 
here with the help of our Reinforcement Learning pipeline by modifying the reward function to be a 
weighted combination of pKi values for the two different targets. Explicitly, we attempt to generate 
molecules that have high binding affinity to the Dopamine Transporter but a much lower binding 
affinity to the Norepinephrine Transporter. Thus, we modify the reward function used in the previous 
experiments to add 2 times the predicted pKi values for Dopamine Transporter and -1 times the 
predicted pKi values for the Norepinephrine Transporter. The higher weight is given to the dopamine 
component since we wish to generate molecules that do bind to it.  Clearly we could use any other 
weightings as part of the reward function, so those chosen are simply illustrative. For this experiment 
we initialize the process with a random molecule from the Dopamine  dataset having a number of 
atoms lower than 25 and choose the expert dataset to be ZINC. The results of this experiment are 
summarized in Supplementary Table 5 and Fig 9. As above, some molecules have a TS of 1 to examples 
in the dataset, for the same reasons. 
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Figure 9. In silico generation by DeepGraphMolGen of novel molecules with predicted binding 
capacity to the dopamine transporter using a generative method in which the number of heavy 
atoms is constrained to be lower than 25. Molecules were generated as described in the text. A. Top 
10 molecules as predicted by DeepGraphMolGen versus the closest molecule in the BindingdB 
dataset and the TS thereto (encoded using the RDKit patterned fingerprint). B. Distribution of 
Tanimoto similarities (RDKit patterned encoding) to the closest molecule in BindingdB dataset of the 
top 500 molecules. C.  Plot of those molecules with differential affinities for the dopamine and 
norepinephrine transporters.  
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Only in rare cases do candidate solutions for multi- (in this case two-)objective optimisation problems 
have unique solutions that are optimal for both [87], and there is a trade-off that is left to the choice 
of the experimenter. Thus, Fig 9C also illustrates the molecules on the Pareto front for the two 
objectives, showing how quite changes in structure can move one swiftly along the Pareto front. 
Consequently our method also provides a convenient means of attacking multi-objective molecular 
optimisation problems. 
 
Conclusions 
Overall, the present molecular graph-based generative method has a number of advantages over 
grammar-based encodings, in particular that it necessarily creates valid molecules.  As stressed by 
Coley and colleagues [49], such methods still retain any inherent limitations of 2D methods as a priori 
they do not encode 3D information. This said, there is evidence that 3D structures do not add much 
benefit when forming QSAR models [88-92], so we do not consider this a major limitation for now. 
Some of the molecules generated might be seen by some (however subjectively) as ‘unusual, even 
though they scored well on both drug-likeness and synthetic accessibility metrics. This probably says 
much about the size of plausible drug space that exists relative to the fraction that has actually been 
explored [93-95], and implies that generative methods can have an important role to play in medicinal 
chemistry. Also, for generating desired molecules, the QSAR models need to be accurate and robust 
in order to evaluate accurately the property of the generated molecules. Recent works such as [96] 
include uncertainty metrics for property discrimination, and benchmarking models are also available 
[97]. In conclusion, we here add to the list of useful, generative molecular methods for virtual 
screening by combining molecular graph encoding, reinforcement learning and multi-objective 
optimisation within a single strategy.  
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